FORMULATION AND EVALUATION OF GLIMEPIRIDE PATCHES FOR TRANSDERMAL DRUG DELIVERY
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 6
Abstract
Transdermal drug delivery has been accepted as a potential non-invasive route of drug administration, with advantages of prolonged therapeutic action, less side effect, easy use and improved patient compliance. “Glimepiride is an anti-diabetic drug with a shorter half life of ~5 hours, low bioavailability and extensive first pass metabolism due to these limitations required to maintain the therapeutic level it has chosen as transdermal drug delivery system.” The present study was to formulate and evaluate transdermal drug delivery system of Glimepiride using polymers such as HPMC & Eudragit RS100 by solvent casting technique. Central composite design (CCD) was applied by using design-expert to optimize composition of HPMC and ERS100 for Transdermal Drug Delivery. The prepared formulations were evaluated for different physicochemical characteristics like Weight Variation, Folding Endurance, Flatness, pH of patches, % Moisture Content, % Moisture uptake, % Elongation, % Drug Content & % Drug Release. The drug release characteristics of the formulation were studied in-vitro by using semi-permeable membrane. The in-vitro drug release plot “showed “ that the drug release followed zero order kinetics & Higuchi model, which was evidenced from the regression values. Based on the drug release and physicochemical values obtained from the formulation F3 is considered as an optimized formulation which shows higher percentage of drug release (97.33±0.26% at 24 hour) with diffusion mediated mechanism. Korsmeyer-Peppas exponential plots shows fairly linear add, it is well supported by their regression coefficient values & slope value (n) were more than 1 which suggest that drug was released by Super Case-II transport. Key words: Transdermal Patches, Transdermal Drug Delivery, Glimepiride, Solvent Casting Method, Central Composite Design & Anti- Diabetic Patches.
Authors and Affiliations
RAHUL SHIVAJIRAO SOLUNKE
Keywords
Related Articles
- EP ID EP418066
- DOI -
- Views 159
- Downloads 0
RETARDATION OF PROGRESSION OF CHRONIC KIDNEY DISEASE THROUGH PHARMACOLOGICAL INTERVENTIONS
Objective: Chronic Kidney Disease (CKD) patients have multiple co-morbidities and complications, and are prescribed with large number of medications. Studies on therapeutic strategies to slow the chronic kidney disease p...
Recent advances in the treatment of Sepsis and septic shock; potential therapy based on biochemical evidence
The clinical syndrome sepsis and septic shock comprise of disorders which are increasingly common, potentially lethal, yet not clearly understood clinical syndromes. The rise in the incidence is well documented and thoug...
CLINICAL EVALUATION OF AN IN-OFFICE APPLICATION OF TWO COMMERCIALLY AVAILABLE DENTIFRICES ON DENTINE HYPERSENSITIVITY IN CHRONIC PERIODONTITIS PATIENTS
Aim: To evaluate the clinical effectiveness of an in-office application of desensitizing paste containing 8% arginine calcium carbonate and 5% potassium nitrate paste on dentine hypersensitivity in chronic Periodontitis...
MEDICAL ETHICS: AYURVEDIC VIEW POINT IN PURVIEW OF CHARAK SAMHITA
Ethics are the methods, policies, perspectives which decide a set of guidelines to act in a particular situation and for analyzing complex problem courses. The medical profession is governed by legislation and by code of...
Demonstration the Expression of α-Methyl Acyl-Co EnzymeA Racemase, P63 and high- molecular-weight cytokeratin in Prostate biopsies in Khartoum State Hospitals
Prostate cancer is the major health problem throughout the world. PCa remains the most common malignancy affecting men and the second leading cause of cancer-related death of men. The immunohistochemistry plays a very im...